RDY Annual Revenue
$3.37 B
+$305.44 M+9.96%
31 March 2024
Summary:
As of January 23, 2025, RDY annual revenue is $3.37 billion, with the most recent change of +$305.44 million (+9.96%) on March 31, 2024. During the last 3 years, it has risen by +$821.23 million (+32.19%). RDY annual revenue is now at all-time high.RDY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY Quarterly Revenue
$956.87 M
0.00%
01 September 2024
Summary:
As of January 23, 2025, RDY quarterly revenue is $956.87 millionOver the past year, it has increased by +$124.78 million (+15.00%). RDY quarterly revenue is now at all-time high.RDY Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY TTM Revenue
$2.68 B
0.00%
01 September 2024
Summary:
As of January 23, 2025, RDY TTM revenue is $2.68 billionOver the past year, it has dropped by -$567.04 million (-17.48%). RDY TTM revenue is now -20.63% below its all-time high of $3.37 billion, reached on March 31, 2024.RDY TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | +15.0% | -17.5% |
| 3 y3 years | +32.2% | +32.4% | -7.0% |
| 5 y5 years | +53.3% | +32.4% | -7.0% |
RDY Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.2% | at high | +41.5% | -20.6% | at low |
| 5 y | 5-year | at high | +53.3% | at high | +65.0% | -20.6% | +10.7% |
| alltime | all time | at high | +1310.0% | at high | +1404.0% | -20.6% | +4106.6% |
Dr Reddys Laboratories Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $956.87 M(+12.2%) | $2.68 B(-20.6%) |
| Mar 2024 | $3.37 B(+10.0%) | $852.90 M(-1.6%) | $3.37 B(+2.6%) |
| Dec 2023 | - | $866.49 M(+4.1%) | $3.29 B(+1.3%) |
| Sept 2023 | - | $832.09 M(+1.4%) | $3.24 B(+1.3%) |
| June 2023 | - | $820.20 M(+7.0%) | $3.20 B(+4.7%) |
| Mar 2023 | $3.07 B(+6.6%) | $766.58 M(-7.0%) | $3.06 B(+1.4%) |
| Dec 2022 | - | $824.43 M(+4.3%) | $3.01 B(+4.0%) |
| Sept 2022 | - | $790.40 M(+16.9%) | $2.90 B(+0.4%) |
| June 2022 | - | $675.99 M(-6.5%) | $2.89 B(+0.3%) |
| Mar 2022 | $2.88 B(+12.8%) | $722.88 M(+1.9%) | $2.88 B(+2.7%) |
| Dec 2021 | - | $709.67 M(-8.8%) | $2.80 B(+1.6%) |
| Sept 2021 | - | $777.79 M(+16.6%) | $2.76 B(+4.6%) |
| June 2021 | - | $667.07 M(+2.9%) | $2.64 B(+3.4%) |
| Mar 2021 | $2.55 B(+3.8%) | $648.45 M(-2.7%) | $2.55 B(+1.5%) |
| Dec 2020 | - | $666.53 M(+1.5%) | $2.51 B(+2.1%) |
| Sept 2020 | - | $656.94 M(+13.3%) | $2.46 B(-1.0%) |
| June 2020 | - | $579.84 M(-5.0%) | $2.49 B(+1.1%) |
| Mar 2020 | $2.46 B(+11.8%) | $610.26 M(-0.7%) | $2.46 B(+1.7%) |
| Dec 2019 | - | $614.83 M(-9.7%) | $2.42 B(+3.5%) |
| Sept 2019 | - | $680.72 M(+23.4%) | $2.34 B(+6.3%) |
| June 2019 | - | $551.63 M(-3.1%) | $2.20 B(-0.2%) |
| Mar 2019 | $2.20 B(-0.2%) | $569.54 M(+6.7%) | $2.20 B(+0.9%) |
| Dec 2018 | - | $533.62 M(-1.4%) | $2.18 B(-2.4%) |
| Sept 2018 | - | $541.33 M(-2.5%) | $2.23 B(-0.5%) |
| June 2018 | - | $555.04 M(+1.0%) | $2.24 B(+1.9%) |
| Mar 2018 | $2.20 B(+4.9%) | $549.32 M(-6.6%) | $2.20 B(+0.9%) |
| Dec 2017 | - | $588.29 M(+6.7%) | $2.18 B(+1.8%) |
| Sept 2017 | - | $551.59 M(+7.3%) | $2.15 B(+0.7%) |
| June 2017 | - | $514.11 M(-3.1%) | $2.13 B(+1.5%) |
| Mar 2017 | $2.10 B(-11.2%) | $530.64 M(-3.5%) | $2.10 B(-1.2%) |
| Dec 2016 | - | $549.90 M(+2.7%) | $2.13 B(-2.4%) |
| Sept 2016 | - | $535.67 M(+10.8%) | $2.18 B(-3.5%) |
| June 2016 | - | $483.42 M(-13.1%) | $2.26 B(-4.6%) |
| Mar 2016 | $2.36 B(-2.4%) | $556.39 M(-7.6%) | $2.37 B(-2.7%) |
| Dec 2015 | - | $601.91 M(-2.0%) | $2.43 B(-0.8%) |
| Sept 2015 | - | $614.45 M(+3.7%) | $2.45 B(+0.9%) |
| June 2015 | - | $592.63 M(-4.7%) | $2.43 B(+0.2%) |
| Mar 2015 | $2.42 B(+10.5%) | $621.76 M(+0.2%) | $2.42 B(+2.5%) |
| Dec 2014 | - | $620.36 M(+4.8%) | $2.36 B(+2.2%) |
| Sept 2014 | - | $591.85 M(+0.6%) | $2.31 B(+2.3%) |
| June 2014 | - | $588.07 M(+4.4%) | $2.26 B(+3.5%) |
| Mar 2014 | $2.19 B(+2.5%) | $563.30 M(-1.1%) | $2.18 B(-2.4%) |
| Dec 2013 | - | $569.80 M(+5.4%) | $2.24 B(+1.9%) |
| Sept 2013 | - | $540.64 M(+5.8%) | $2.20 B(+0.9%) |
| June 2013 | - | $510.91 M(-17.1%) | $2.18 B(+1.9%) |
| Mar 2013 | $2.14 B | $616.30 M(+16.5%) | $2.14 B(+11.7%) |
| Dec 2012 | - | $528.94 M(+1.3%) | $1.92 B(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $521.96 M(+10.8%) | $1.93 B(+1.3%) |
| June 2012 | - | $471.27 M(+19.9%) | $1.91 B(+1.5%) |
| Mar 2012 | $2.03 B(+23.6%) | $393.06 M(-28.0%) | $1.88 B(-2.8%) |
| Dec 2011 | - | $545.81 M(+10.0%) | $1.93 B(+6.7%) |
| Sept 2011 | - | $496.32 M(+12.1%) | $1.81 B(+5.5%) |
| June 2011 | - | $442.84 M(-0.8%) | $1.72 B(+4.5%) |
| Mar 2011 | $1.64 B(+10.6%) | $446.26 M(+5.3%) | $1.64 B(+5.7%) |
| Dec 2010 | - | $423.94 M(+5.3%) | $1.55 B(+3.5%) |
| Sept 2010 | - | $402.74 M(+9.1%) | $1.50 B(+1.5%) |
| June 2010 | - | $369.09 M(+3.1%) | $1.48 B(-0.3%) |
| Mar 2010 | $1.48 B(-1.9%) | $358.17 M(-3.6%) | $1.48 B(-2.8%) |
| Dec 2009 | - | $371.45 M(-2.2%) | $1.53 B(-0.4%) |
| Sept 2009 | - | $379.90 M(+1.7%) | $1.53 B(+0.9%) |
| June 2009 | - | $373.55 M(-6.6%) | $1.52 B(+0.8%) |
| Mar 2009 | $1.51 B(+21.3%) | $400.16 M(+5.8%) | $1.51 B(+4.6%) |
| Dec 2008 | - | $378.12 M(+3.3%) | $1.44 B(+4.7%) |
| Sept 2008 | - | $365.99 M(+1.4%) | $1.37 B(+4.9%) |
| June 2008 | - | $361.02 M(+8.1%) | $1.31 B(+5.5%) |
| Mar 2008 | $1.25 B(-13.8%) | $334.03 M(+6.6%) | $1.24 B(-1.6%) |
| Dec 2007 | - | $313.36 M(+3.7%) | $1.26 B(-2.5%) |
| Sept 2007 | - | $302.20 M(+3.4%) | $1.29 B(-9.1%) |
| June 2007 | - | $292.40 M(-17.6%) | $1.42 B(-1.3%) |
| Mar 2007 | $1.45 B(+162.6%) | $354.83 M(+2.7%) | $1.44 B(+15.8%) |
| Dec 2006 | - | $345.40 M(-20.0%) | $1.25 B(+20.8%) |
| Sept 2006 | - | $431.94 M(+39.1%) | $1.03 B(+40.7%) |
| June 2006 | - | $310.63 M(+96.4%) | $733.00 M(+33.1%) |
| Mar 2006 | $551.38 M(+26.5%) | $158.19 M(+21.0%) | $550.88 M(+6.4%) |
| Dec 2005 | - | $130.73 M(-2.0%) | $517.80 M(+6.9%) |
| Sept 2005 | - | $133.45 M(+3.8%) | $484.32 M(+3.4%) |
| June 2005 | - | $128.51 M(+2.7%) | $468.30 M(+3.2%) |
| Mar 2005 | $435.94 M(-0.5%) | $125.11 M(+28.7%) | $453.89 M(+4.3%) |
| Dec 2004 | - | $97.25 M(-17.2%) | $435.09 M(-3.5%) |
| Sept 2004 | - | $117.43 M(+2.9%) | $450.92 M(+0.0%) |
| June 2004 | - | $114.09 M(+7.3%) | $450.74 M(+2.6%) |
| Mar 2004 | $438.20 M(+17.8%) | $106.32 M(-6.0%) | $439.19 M(+4.4%) |
| Dec 2003 | - | $113.08 M(-3.6%) | $420.71 M(+5.7%) |
| Sept 2003 | - | $117.25 M(+14.3%) | $398.05 M(+4.1%) |
| June 2003 | - | $102.54 M(+16.7%) | $382.37 M(+2.7%) |
| Mar 2003 | $372.07 M(+7.0%) | $87.84 M(-2.9%) | $372.48 M(+1.8%) |
| Dec 2002 | - | $90.42 M(-11.0%) | $365.93 M(-1.3%) |
| Sept 2002 | - | $101.58 M(+9.6%) | $370.66 M(-1.6%) |
| June 2002 | - | $92.64 M(+14.0%) | $376.58 M(+8.4%) |
| Mar 2002 | $347.63 M(+45.4%) | $81.29 M(-14.6%) | $347.56 M(+30.5%) |
| Dec 2001 | - | $95.15 M(-11.5%) | $266.27 M(+55.6%) |
| Sept 2001 | - | $107.50 M(+69.0%) | $171.12 M(+169.0%) |
| June 2001 | - | $63.62 M | $63.62 M |
| Mar 2001 | $239.16 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual revenue?
- What is the all time high annual revenue for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual revenue year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly revenue?
- What is the all time high quarterly revenue for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly revenue year-on-year change?
- What is Dr Reddys Laboratories Limited TTM revenue?
- What is the all time high TTM revenue for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM revenue year-on-year change?
What is Dr Reddys Laboratories Limited annual revenue?
The current annual revenue of RDY is $3.37 B
What is the all time high annual revenue for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual revenue is $3.37 B
What is Dr Reddys Laboratories Limited annual revenue year-on-year change?
Over the past year, RDY annual revenue has changed by +$305.44 M (+9.96%)
What is Dr Reddys Laboratories Limited quarterly revenue?
The current quarterly revenue of RDY is $956.87 M
What is the all time high quarterly revenue for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly revenue is $956.87 M
What is Dr Reddys Laboratories Limited quarterly revenue year-on-year change?
Over the past year, RDY quarterly revenue has changed by +$124.78 M (+15.00%)
What is Dr Reddys Laboratories Limited TTM revenue?
The current TTM revenue of RDY is $2.68 B
What is the all time high TTM revenue for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM revenue is $3.37 B
What is Dr Reddys Laboratories Limited TTM revenue year-on-year change?
Over the past year, RDY TTM revenue has changed by -$567.04 M (-17.48%)